BBDC Newsletter
| BBDC NEWS | Vol. 9, No. 4 -- June 2009 |
|---|
UPCOMING EVENTS
RECENT ADVANCES IN BETA CELL BIOLOGY: SCIENTIFIC AND CLINICAL
IMPLICATIONS
This official academic satellite symposium of the International Diabetes Federation 20th World Diabetes Congress will be held October 16-17, 2009 at the Sheraton Centre in downtown Toronto. The symposium will highlight very recent advances in our understanding of beta cell biology with a focus on translational relevance and implications for the treatment of both type 1 and type 2 diabetes. Participants are invited to submit abstracts for oral and poster presentations at the symposium. Abstracts related to all aspects of beta cell biology are welcome and must be submitted online by July 15, 2009. Detailed information regarding abstract guidelines, program and registration is available on the symposium web site at www.betacell2009.ca.
FUNDING OPPORTUNITIES
IMPORTANT NOTICE: The
TRAINEE TRAVEL AWARDS
2009/2010 (PERIOD 1)
FOR TRAVEL OCCURRING BETWEEN JULY 1 AND DECEMBER 31, 2009
Awards of up to $1,000 (Canadian) are available to
trainees who will be traveling to a national or international meeting
between July 1 and December 31, 2009 to present a first-author abstract.
The content of the abstract must be directly related to an area of
diabetes research. To be eligible, applicants must be registered
graduate students, post-doctoral or clinical fellows conducting diabetes
research at the University of Toronto or one of its affiliated
institutions. The trainee’s supervisor must hold a full-time
faculty appointment with the University of Toronto and must also be a
registered member* of the BBDC at the time of application submission.
The deadline for receipt of applications is 5 p.m., October 6,
2009. For complete award details and application
instructions please see the following web page:
http://www.bbdc.org/fundingOpp/travel.htm
.
Upcoming Funding
Opportunities:
- Pilot Grants for Innovative Activities Related to Diabetes Education, Management, and Care 2010/2011: Deadline for Letters of Intent: September 2009
- Reuben & Helene Dennis Scholar in Diabetes Research 2010-2012: Application deadline October 2009
- Diabetes Educator of the Year (2009):
Nomination deadline November 2009
* Those who are new to the field of diabetes research, education or care and are not members of the BBDC can request free membership by contacting the Centre prior to submitting an application. For more information about BBDC Membership, please view the MEMBERSHIP section of our web site at http://www.bbdc.org/membership/index.htm .
AWARD RESULTS**
ANNUAL TRAINEE AWARDS 2008/2009
| Applicant |
Supervisor |
Abstract Title |
Prize |
|---|---|---|---|
|
Meghan Sauvé |
Dr. Daniel Drucker |
Genetic deletion or selective inhibition of Dipeptidyl Peptidase-4 improves
cardiovascular outcomes following myocardial infarction in mice |
1st Prize |
|
Sylvia Ley |
Dr. Anthony Hanley |
Interaction Between the HNF1A G319S Variant and Active Cigarette Smoking Influences the Development of Type 2 Diabetes | 2nd Prize |
| Xiaomiao Lan-Pidhainy |
Dr. Thomas Wolever |
Attenuated GLP-1 response after oral glucose is associated with impaired
beta-cell function |
3rd Prize |
|
Madhu Chari |
Dr. Tony Lam |
Lowering Plasma Glucose Levels in Diabetes Rescues Hypothalamic Glucose-Sensing
and Normalizes Hypothalamic Glucose Transporter-1 |
Honourable Mention |
|
Diana Choi |
Dr. Minna Woo |
Cytoprotective effects of erythropoietin against beta-cell apoptosis in type 1
and type 2 diabetes models |
Honourable Mention |
|
Christine Tang |
Dr. Adria Giacca |
Glucose-induced Beta-Cell Dysfunction In Vivo: Role of Endoplasmic
Reticulum Stress |
Honourable Mention |
TRAINEE TRAVEL AWARDS 2008/2009 (pERIOD 2)
FOR TRAVEL OCCURRING BETWEEN JANUARY 1 AND JULY 31, 2009
| Applicant |
Supervisor(s) |
Abstract Title |
|---|---|---|
|
Safina Ali |
Dr. Daniel Drucker |
The Role of the GLP-1 Receptor in the Improved Metabolic Phenotype of Gcgr-/-
mice |
|
Danna Breen |
Dr. Adria Giacca |
Effect of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic
insulin sensitivity. |
|
Yin Chan |
Dr. Hans-Michael Dosch |
Normalization of Obesity-Associated Insulin Resistance Through Immunotherapy:
CD4+ T Cells Control Homeostasis |
|
Gary Chao |
Dr. Philippe Poussier |
Evidence for linkage of Type 1 Diabetes (T1D) resistance and upregulation of
eotaxin (CCL11) in pancreatic beta cells to a chromosome 12 locus in the
Biobreeding rat |
|
Madhu Chari |
Dr. Tony Lam |
Lowering Plasma Glucose Levels in Diabetes Rescues Hypothalamic Glucose-Sensing
and Normalizes Hypothalamic Glucose Transporter-1 |
| Grace Wing Chee Cheung |
Dr. Tony Lam |
Duodenal cholecystokinin triggers a gut-brain-liver axis to regulate glucose
production |
|
Tim Chiu |
Dr. Amira Klip |
Signals and Subcellular Steps in GLUT4 Translocation Affected in Insulin
Residence |
|
Diana Choi |
Dr. Minna Woo |
Exogenous recombinant erythropoietin protects mice against type 1 and type 2
diabetes |
|
Irene Hadjiyanni |
Dr. Daniel Drucker |
The Role of the GLP-1 Receptor in the Murine Immune system |
|
Xiaomiao Lan-Pidhainy |
Dr. Thomas Wolever |
Attenuated GLP-1 response after oral glucose is associated with impaired β-cell
function |
|
Rachel Masters |
Dr. Anthony Hanley |
Associations of whole and refined grain intakes with inflammatory proteins in
diabetic subjects: The Insulin Resistance Atherosclerosis Study (IRAS) |
|
Jonathan Schertzer |
Dr. Amira Klip |
Insulin-induced changes in cell surface GLUT4 and GLUT4-ineracting proteins in
skeletal muscle of transgenic GLUT4myc-expressing mice |
|
Linyuan Wang |
Dr. Minna Woo |
Ventromedial hypothalamic PTEN regulates peripheral insulin sensitivity through
adipogenesis |
|
Li Xie |
Dr. Herbert Gaisano |
Ra1A GTPase regulation of insulin exocytosis involves Ra1A interactions with
L-and R-type calcium channels |
|
Jessica Yue |
Dr. Mladen Vranic & |
Normalization of the Glucagon Response to Hypoglycemia in STZ-Diabetic Rats via
Somatostatin Type 2 Receptor Antagonism |
|
Liang Xi |
Dr. Gary Lewis |
Acute Administration of C-Reactive Protein Elevates Plasma TNF-α Levels and
Induces Hepatic Insulin Resistance in Sprague-Dawley Rats |
** An essential condition of all BBDC programs is the acknowledgement of BBDC support, where appropriate, in all publications relevant to the BBDC-supported research program. Failure to appropriately acknowledge the BBDC’s support in relevant publications will be considered grounds for suspending future eligibility for BBDC funding programs.
BBDC CORE LABORATORY
The BBDC Core Laboratory provides analytical and technical support to
the
ACKNOWLEDGEMENTS
We would like to express our sincerest gratitude and appreciation to the
following people:
- The members of our Research Committee and our Diabetes Care and Education Committee who volunteer their time to review applications for the Centre’s funding programs and to organize educational events on behalf of the BBDC.
- Everyone
who participated in Diabetes Update 2009.
- Everyone
who participated in our 20th Annual Scientific Day.
- Dr. Allen Volchuk,
our 2009 Charles Hollenberg Summer Studentship Program Coordinator
- The BBDC members who provided scientific reviews for
various BBDC funding programs this past year.
- The following supporters who have helped make our educational
events possible over the past year: Abbott, Animas Canada,
Bristol-Myers Squibb Canada and AstraZeneca, Eli Lilly Canada,
GlaxoSmithKline, LifeScan Canada, Medtronic Diabetes, Merck Frosst
Canada, Novo Nordisk Canada, Pfizer Canada, Roche, Sanofi-Aventis,
and Servier Canada
BBDC News is published in September, December, March and June of each year.
Current and past issues are available on our web site.
DIRECTOR: DANIEL J. DRUCKER, MD, FRCPC
Banting and Best Diabetes Centre
Faculty of Medicine, University of Toronto
Located at the Toronto General Hospital
200 Elizabeth Street
Eaton Building, 12th Floor, Room
12E248
Toronto, Ontario M5G 2C4
Phone: (416) 978-4656 • Fax: (416) 978-4108
E-mail:
diabetes.bbdc@utoronto.ca • Website:
www.bbdc.org